ID   CASP8_RAT               Reviewed;         482 AA.
AC   Q9JHX4;
DT   01-APR-2015, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 171.
DE   RecName: Full=Caspase-8 {ECO:0000303|PubMed:10197541, ECO:0000303|Ref.2};
DE            Short=CASP-8 {ECO:0000303|PubMed:10197541};
DE            EC=3.4.22.61 {ECO:0000250|UniProtKB:O89110};
DE   Contains:
DE     RecName: Full=Caspase-8 subunit p18 {ECO:0000250|UniProtKB:Q14790};
DE   Contains:
DE     RecName: Full=Caspase-8 subunit p10 {ECO:0000250|UniProtKB:Q14790};
DE   Flags: Precursor;
GN   Name=Casp8 {ECO:0000303|PubMed:10197541, ECO:0000312|RGD:620945};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Itoh T., Itoh A., Pleasure D.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Cerebellum;
RA   Cao G., Graham S.H., Chen D., Chen J.;
RT   "Molecular cloning and characterization of rat caspase-8: Its implication
RT   in delayed neuronal cell death after ischemia.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10197541; DOI=10.1016/s0896-6273(00)80716-3;
RA   Sanchez I., Xu C.J., Juo P., Kakizaka A., Blenis J., Yuan J.;
RT   "Caspase-8 is required for cell death induced by expanded polyglutamine
RT   repeats.";
RL   Neuron 22:623-633(1999).
RN   [6]
RP   INTERACTION WITH NOL3.
RX   PubMed=15383280; DOI=10.1016/j.molcel.2004.08.020;
RA   Nam Y.J., Mani K., Ashton A.W., Peng C.F., Krishnamurthy B., Hayakawa Y.,
RA   Lee P., Korsmeyer S.J., Kitsis R.N.;
RT   "Inhibition of both the extrinsic and intrinsic death pathways through
RT   nonhomotypic death-fold interactions.";
RL   Mol. Cell 15:901-912(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Thiol protease that plays a key role in programmed cell death
CC       by acting as a molecular switch for apoptosis, necroptosis and
CC       pyroptosis, and is required to prevent tissue damage during embryonic
CC       development and adulthood (By similarity). Initiator protease that
CC       induces extrinsic apoptosis by mediating cleavage and activation of
CC       effector caspases responsible for FAS/CD95-mediated and TNFRSF1A-
CC       induced cell death (PubMed:10197541). Cleaves and activates effector
CC       caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (By similarity).
CC       Binding to the adapter molecule FADD recruits it to either receptor
CC       FAS/CD95 or TNFRSF1A (PubMed:10197541). The resulting aggregate called
CC       the death-inducing signaling complex (DISC) performs CASP8 proteolytic
CC       activation (By similarity). The active dimeric enzyme is then liberated
CC       from the DISC and free to activate downstream apoptotic proteases (By
CC       similarity). Proteolytic fragments of the N-terminal propeptide (termed
CC       CAP3, CAP5 and CAP6) are likely retained in the DISC (By similarity).
CC       In addition to extrinsic apoptosis, also acts as a negative regulator
CC       of necroptosis: acts by cleaving RIPK1 at 'Asp-325', which is crucial
CC       to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis,
CC       necroptosis and inflammatory response (By similarity). Also able to
CC       initiate pyroptosis by mediating cleavage and activation of gasdermin-C
CC       and -D (GSDMC and GSDMD, respectively): gasdermin cleavage promotes
CC       release of the N-terminal moiety that binds to membranes and forms
CC       pores, triggering pyroptosis (By similarity). Initiates pyroptosis
CC       following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a
CC       regulator of innate immunity by mediating cleavage and inactivation of
CC       N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production
CC       (By similarity). May participate in the Granzyme B (GZMB) cell death
CC       pathways (By similarity). Cleaves PARP1 and PARP2 (By similarity).
CC       {ECO:0000250|UniProtKB:O89110, ECO:0000250|UniProtKB:Q14790,
CC       ECO:0000269|PubMed:10197541}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for Asp at position P1 and has a preferred
CC         cleavage sequence of (Leu/Asp/Val)-Glu-Thr-Asp-|-(Gly/Ser/Ala).;
CC         EC=3.4.22.61; Evidence={ECO:0000250|UniProtKB:O89110};
CC   -!- ACTIVITY REGULATION: CASP8 activity is restricted by RIPK1.
CC       {ECO:0000250|UniProtKB:O89110}.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel arranged
CC       heterodimers, each one formed by a 18 kDa (p18) and a 10 kDa (p10)
CC       subunit (By similarity). Component of the death-induced signaling
CC       complex (DISC) composed of cell surface receptor FAS/CD95 or TNFRSF1A,
CC       adapter protein FADD and the CASP8 protease; recruitment of CASP8 to
CC       the complex is required for processing of CASP8 into the p18 and p10
CC       subunits (By similarity). Component of the AIM2 PANoptosome complex, a
CC       multiprotein complex that drives inflammatory cell death (PANoptosis)
CC       (By similarity). Interacts with CFLAR and PEA15 (By similarity).
CC       Interacts with RFFL and RNF34; negatively regulate CASP8 through
CC       proteasomal degradation (By similarity). Interacts with TNFAIP8L2 (By
CC       similarity). Interacts with CASP8AP2 (By similarity). Interacts with
CC       NOL3; decreases CASP8 activity in a mitochondria localization- and
CC       phosphorylation-dependent manner and this interaction is dissociated by
CC       calcium (PubMed:15383280). Interacts with UBR2 (By similarity).
CC       Interacts with RIPK1 (By similarity). Interacts with stimulated
CC       TNFRSF10B; this interaction is followed by CASP8 proteolytic cleavage
CC       and activation (By similarity). {ECO:0000250|UniProtKB:O89110,
CC       ECO:0000250|UniProtKB:Q14790, ECO:0000269|PubMed:15383280}.
CC   -!- INTERACTION:
CC       Q9JHX4; Q8R2E7: Fadd; NbExp=2; IntAct=EBI-4326675, EBI-4326723;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10197541}. Nucleus
CC       {ECO:0000269|PubMed:10197541}.
CC   -!- PTM: Generation of the subunits requires association with the death-
CC       inducing signaling complex (DISC), whereas additional processing is
CC       likely due to the autocatalytic activity of the activated protease.
CC       GZMB and CASP10 can be involved in these processing events (By
CC       similarity). {ECO:0000250|UniProtKB:Q14790}.
CC   -!- PTM: Phosphorylation on Ser-389 during mitosis by CDK1 inhibits
CC       activation by proteolysis and prevents apoptosis. This phosphorylation
CC       occurs in cancer cell lines, as well as in primary breast tissues and
CC       lymphocytes (By similarity). {ECO:0000250|UniProtKB:Q14790}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF279308; AAF87778.1; -; mRNA.
DR   EMBL; AF288372; AAK83055.1; -; mRNA.
DR   EMBL; AABR06060567; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06060568; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473965; EDL98978.1; -; Genomic_DNA.
DR   EMBL; CH473965; EDL98979.1; -; Genomic_DNA.
DR   RefSeq; NP_071613.1; NM_022277.1.
DR   RefSeq; XP_006245077.1; XM_006245015.3.
DR   AlphaFoldDB; Q9JHX4; -.
DR   SMR; Q9JHX4; -.
DR   IntAct; Q9JHX4; 2.
DR   STRING; 10116.ENSRNOP00000016613; -.
DR   MEROPS; C14.009; -.
DR   iPTMnet; Q9JHX4; -.
DR   PhosphoSitePlus; Q9JHX4; -.
DR   PaxDb; 10116-ENSRNOP00000016613; -.
DR   Ensembl; ENSRNOT00000016613.5; ENSRNOP00000016613.2; ENSRNOG00000012331.7.
DR   Ensembl; ENSRNOT00055039920; ENSRNOP00055032394; ENSRNOG00055023227.
DR   Ensembl; ENSRNOT00060029215; ENSRNOP00060023524; ENSRNOG00060017095.
DR   Ensembl; ENSRNOT00065050115; ENSRNOP00065041174; ENSRNOG00065029007.
DR   GeneID; 64044; -.
DR   KEGG; rno:64044; -.
DR   UCSC; RGD:620945; rat.
DR   AGR; RGD:620945; -.
DR   CTD; 841; -.
DR   RGD; 620945; Casp8.
DR   eggNOG; KOG3573; Eukaryota.
DR   GeneTree; ENSGT00940000160319; -.
DR   HOGENOM; CLU_036904_4_2_1; -.
DR   InParanoid; Q9JHX4; -.
DR   OMA; WNRIEDG; -.
DR   OrthoDB; 2873736at2759; -.
DR   PhylomeDB; Q9JHX4; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.61; 5301.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-140534; Caspase activation via Death Receptors in the presence of ligand.
DR   Reactome; R-RNO-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-RNO-2562578; TRIF-mediated programmed cell death.
DR   Reactome; R-RNO-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-RNO-3371378; Regulation by c-FLIP.
DR   Reactome; R-RNO-5218900; CASP8 activity is inhibited.
DR   Reactome; R-RNO-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-RNO-5660668; CLEC7A/inflammasome pathway.
DR   Reactome; R-RNO-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-RNO-69416; Dimerization of procaspase-8.
DR   Reactome; R-RNO-75108; Activation, myristolyation of BID and translocation to mitochondria.
DR   Reactome; R-RNO-75153; Apoptotic execution phase.
DR   Reactome; R-RNO-75157; FasL/ CD95L signaling.
DR   Reactome; R-RNO-75158; TRAIL signaling.
DR   Reactome; R-RNO-9758274; Regulation of NF-kappa B signaling.
DR   PRO; PR:Q9JHX4; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Proteomes; UP000234681; Chromosome 9.
DR   Bgee; ENSRNOG00000012331; Expressed in thymus and 18 other cell types or tissues.
DR   GO; GO:0031265; C:CD95 death-inducing signaling complex; IDA:RGD.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0031264; C:death-inducing signaling complex; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0030690; C:Noc1p-Noc2p complex; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0097342; C:ripoptosome; ISS:UniProtKB.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; ISO:RGD.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:RGD.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0035877; F:death effector domain binding; ISO:RGD.
DR   GO; GO:0005123; F:death receptor binding; IPI:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008233; F:peptidase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0097194; P:execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0030225; P:macrophage differentiation; ISO:RGD.
DR   GO; GO:0070266; P:necroptotic process; ISO:RGD.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0060546; P:negative regulation of necroptotic process; ISS:UniProtKB.
DR   GO; GO:0001841; P:neural tube formation; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISO:RGD.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; ISO:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:0016485; P:protein processing; IDA:RGD.
DR   GO; GO:0006508; P:proteolysis; ISO:RGD.
DR   GO; GO:0051603; P:proteolysis involved in protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0070269; P:pyroptotic inflammatory response; ISS:UniProtKB.
DR   GO; GO:2001233; P:regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0001817; P:regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0045088; P:regulation of innate immune response; ISS:UniProtKB.
DR   GO; GO:0070243; P:regulation of thymocyte apoptotic process; ISO:RGD.
DR   GO; GO:0032025; P:response to cobalt ion; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0097264; P:self proteolysis; ISS:UniProtKB.
DR   GO; GO:0036462; P:TRAIL-activated apoptotic signaling pathway; ISO:RGD.
DR   CDD; cd00032; CASc; 1.
DR   CDD; cd08333; DED_Caspase_8_r1; 1.
DR   Gene3D; 3.40.50.1460; -; 1.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 2.
DR   InterPro; IPR051290; CASP8/FADD-like_regulator.
DR   InterPro; IPR033170; Caspase-8_DED1.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR001875; DED_dom.
DR   InterPro; IPR011600; Pept_C14_caspase.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR48169:SF5; CASPASE 10; 1.
DR   PANTHER; PTHR48169; DED DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF01335; DED; 2.
DR   Pfam; PF00656; Peptidase_C14; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SMART; SM00031; DED; 2.
DR   SUPFAM; SSF52129; Caspase-like; 1.
DR   SUPFAM; SSF47986; DEATH domain; 2.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
DR   PROSITE; PS50168; DED; 2.
PE   1: Evidence at protein level;
KW   Apoptosis; Cytoplasm; Hydrolase; Nucleus; Phosphoprotein; Protease;
KW   Reference proteome; Repeat; Thiol protease; Zymogen.
FT   PROPEP          1..218
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT                   /id="PRO_0000432425"
FT   CHAIN           219..378
FT                   /note="Caspase-8 subunit p18"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT                   /id="PRO_0000432426"
FT   PROPEP          379..388
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT                   /id="PRO_0000432427"
FT   CHAIN           389..482
FT                   /note="Caspase-8 subunit p10"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT                   /id="PRO_0000432428"
FT   DOMAIN          2..80
FT                   /note="DED 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00065"
FT   DOMAIN          100..177
FT                   /note="DED 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00065"
FT   ACT_SITE        319
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   ACT_SITE        362
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   SITE            218..219
FT                   /note="Cleavage; by autocatalytic cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   SITE            376..377
FT                   /note="Cleavage; by CASP6"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   SITE            388..389
FT                   /note="Cleavage; by autocatalytic cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   MOD_RES         188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O89110"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O89110"
FT   MOD_RES         336
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
FT   MOD_RES         390
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q14790"
SQ   SEQUENCE   482 AA;  55339 MW;  82B4A29330C53264 CRC64;
     MDFHSCLYDI AERLGNEELA ALKFLCLDHI PQKKQESIND VLVLFQRLQE EGMLEEDNLS
     FLKELLFHIS RRDLLSRVLK SSPEEMVREL QVLGKAQVSA YRVMLFKLSE DMDKEDLKSF
     KFLLITEIPK CKLQDNSSLL DIFVEMEKRT ILAENNLVTL KSICFRVNRS LLGRIDDYER
     SSTERRMSTE GGEELPVSVL DEVTIKMQDM WDSPGEQESE SLNSDNVYQM KSKPRGYCLI
     FNNNNFSKAR EDIPKLSNMR DRKGTNYDEE ALSKTFKELH FEIVSFSDCT ASQIHEVLVS
     YQSKDHKGKD CFICCILSHG DKGIVYGTDG KEASIYELTS YFTGSKCPSL AGKPKIFFIQ
     ACQGNNFQKA VPVPDETGLE QEHVLEEDSS SYKNYIPDEA DFLLGMATVK NCVSYRDPTR
     GTWYIQSLCQ SLRERCPRGE DILSILTGVN YDVSNKDNPR NMGKQMPQPI FTLRKKLFFP
     PN
//
